Cargando…
Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309510/ https://www.ncbi.nlm.nih.gov/pubmed/36806200 http://dx.doi.org/10.1097/CM9.0000000000002481 |
| _version_ | 1785066456050827264 |
|---|---|
| author | Chen, Shumin Li, Ye Wang, Zheng Feng, Lin Jia, Yueping Mo, Xiaodong Wang, Yu Jiang, Qian Huang, Xiaojun Lai, Yueyun |
| author_facet | Chen, Shumin Li, Ye Wang, Zheng Feng, Lin Jia, Yueping Mo, Xiaodong Wang, Yu Jiang, Qian Huang, Xiaojun Lai, Yueyun |
| author_sort | Chen, Shumin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10309510 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103095102023-06-30 Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor Chen, Shumin Li, Ye Wang, Zheng Feng, Lin Jia, Yueping Mo, Xiaodong Wang, Yu Jiang, Qian Huang, Xiaojun Lai, Yueyun Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-06-05 2023-02-15 /pmc/articles/PMC10309510/ /pubmed/36806200 http://dx.doi.org/10.1097/CM9.0000000000002481 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Chen, Shumin Li, Ye Wang, Zheng Feng, Lin Jia, Yueping Mo, Xiaodong Wang, Yu Jiang, Qian Huang, Xiaojun Lai, Yueyun Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor |
| title | Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor |
| title_full | Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor |
| title_fullStr | Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor |
| title_full_unstemmed | Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor |
| title_short | Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor |
| title_sort | improved outcomes in e2a::hlf positive b-cell acute lymphoblastic leukemia by chimeric antigen receptor t cell therapy and bcl-2 inhibitor |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309510/ https://www.ncbi.nlm.nih.gov/pubmed/36806200 http://dx.doi.org/10.1097/CM9.0000000000002481 |
| work_keys_str_mv | AT chenshumin improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT liye improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT wangzheng improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT fenglin improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT jiayueping improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT moxiaodong improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT wangyu improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT jiangqian improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT huangxiaojun improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor AT laiyueyun improvedoutcomesine2ahlfpositivebcellacutelymphoblasticleukemiabychimericantigenreceptortcelltherapyandbcl2inhibitor |